Successful removal of biofilm in wounds is contingent upon accurate detection of bacterial burden
Fluorescence imaging (MolecuLight i:X) can detect wound bacteria encased in biofilm, as confirmed by SEM and histopathology
Red fluorescence observed from in vivo polymicrobial wound models is specific to bacteria, and not from an immune response
Fluorescence imaging (MolecuLight i:X) can detect both planktonic & biofilm bacterial cultures
Biofilm is present in more than 70% of chronic wounds and it contributes to delayed healing
Using fluorescence imaging to localize bacteria may facilitate targeted disruption of biofilm & bacterial removal
A pre-clinical mouse wound model demonstrating the safety and feasibility of the fluorescence imaging procedure to visualize elevated bacterial burden in wounds
After treatment with antibiotics, bacterial fluorescence signal correlated with quantitative changes in wound bacterial load
MolecuLight is SOC ll®
Type l Accredited:
MolecuLight awarded
Premier’s Technology
Breakthrough Designation
MolecuLight i:X
is designated as a:
MolecuLight included
in ISWCAP Consensus
Guidelines:
MolecuLight is a proud
corporate member of:
©2024
The MolecuLight® i:X and MolecuLightDX™ Imaging Devices are approved by Health Canada for sale in Canada and has CE marking for sale in the European Union.
The MolecuLight™ i:X and DX Imaging Devices have received FDA clearance.